Pulmonary Disease, Chronic Obstructive: all 4,252 studies

Page 39 of 43. Open to participants first (707), then studies with results posted, then the rest; newest registration first within each.

• Clinical Study to Assess the Effects of SRT2104 and Prednisolone on Biomarkers in Blood in Healthy VolunteersCompletedNCT00920660Phase 1
• The Canadian Cohort Obstructive Lung DiseaseStatus unknownNCT00920348
• Treatment With AKL1 in Obstructive Airways Disease (The TAKL Study)Status unknownNCT00920127Phase 2/3
• Nurse Tele-Consultations With Discharged COPD Patients Reduce the Numbers of ReadmissionsCompletedNCT00918905Not applicable
• Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Inhaled TPI 1100 in Healthy VolunteersWithdrawnNCT00914433Phase 1
• The Effects of Continuous Positive Airway Pressure on Overlap SyndromeCompletedNCT00914264
• Effects of Aerobe Interval Training and Moderate Continuous Training in Chronic Obstructive Pulmonary Disease PatientsCompletedNCT00908765Not applicable
• Impact of Fluticasone and Salmeterol on Airway Dendritic Cells (DCs) in SmokersCompletedNCT00908362Phase 1
• Mucus Dehydration and Evolution of Chronic Obstructive Pulmonary Disease (COPD) Lung DiseaseCompletedNCT00903955
• Role of A Disintegrin and Metalloproteinase (ADAM) in Epithelial DysfunctionCompletedNCT00898859
• Exercise Pulseoximetry for Pre-flight Evaluation of Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00896584
• Patient's Perception in Symptoms Related to Morning Activity Based on Chronic Obstructive Lung DiseaseCompletedNCT00894426
• Randomized Controlled Trial of Home Telemonitoring for Elderly PeopleStatus unknownNCT00893685Not applicable
• Chronic Obstructive Pulmonary Disease (COPD) and Domestic Endotoxin (CODE)CompletedNCT00890136
• Staccato Loxapine Pulmonary Safety in Patients With COPDCompletedNCT00889837Phase 1
• Screening Evaluation for Studies of Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00889447
• ADL- Training for Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00887705Not applicable
• Study of GSK961081 in Healthy Volunteer SubjectsCompletedNCT00887406Phase 1
• Exacerbations and Health Related Quality of Life in Chronic Obstructive Pulmonary DiseaseStatus unknownNCT00884975
• Nutritional Enhancement in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00884299Not applicable
• Granzymes and Perforin at the Onset of Chronic Obstructive Pulmonary Disease (COPD) ExacerbationsCompletedNCT00883701
• IMD-1041 Chronic Obstructive Pulmonary Disease: Proof of Concept (POC) StudyStatus unknownNCT00883584Phase 2
• European Multi-center Post Market Study of the IBV Valve SystemCompletedNCT00880724Not applicable
• Study to Evaluate the Safety and Efficacy of Inhaled PT005 in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00880490Phase 1/2
• Action Plan to Enhance Self-management and Early Detection of Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00879281Not applicable
• Dyspnea and Biomarkers in a Prehospital SettingCompletedNCT00878475
• Oxygen Portable Concentrator During Exercises in Patients With COPDCompletedNCT00875719Not applicable
• Electrostimulation, Skeletal Muscle Function, and Exercise Capacity in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00874965Not applicable
• Long-term Oxygen Treatment (LTOT) in Chronic Obstructive Pulmonary Disease: Factors Influencing SurvivalStatus unknownNCT00871962
• Airway Macrophages and Sputum Milieu in Adult Subjects With Airflow ObstructionCompletedNCT00871637
• Study to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00871182Phase 1/2
• Prevalence and Pathogenesis of Lung Disease in a Large HIV Cohort-coordinating CenterCompletedNCT00870857
• Diaphragmatic Mobility and Chronic Obstructive Pulmonary DiseaseCompletedNCT00870246
• Pneumocystis in Pathogenesis of HIV-associated EmphysemaCompletedNCT00869544
• Drug Interaction Study to Investigate Co-administration of GW642444M With KetoconazoleCompletedNCT00866515Phase 1
• Multiorgan Pathology in Chronic Obstructive Pulmonary Disease (COPD)Status unknownNCT00864994
• Clinical Outcomes of Tiotropium Plus Fluticasone Propionate/Salmeterol Compared With Tiotropium for Chronic Obstructive Pulmonary Disease (COPD) in KoreaCompletedNCT00864812Phase 4
• Multiple Dose Healthy Volunteer Safety Pharmacokinetics StudyCompletedNCT00864786Phase 1
• High Frequency Chest Wall Oscillation in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00863616Not applicable
• Serum, Plasma, DNA and Tissue Bank in Chronic Obstructive Pulmonary Disease and Lung CancerStatus unknownNCT00858520
• Doxycycline and Airway Inflammation in Chronic Obstructive Pulmonary Disease (COPD)Status unknownNCT00857038Phase 4
• Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Chronic Heart Failure and Chronic Obstructive Pulmonary Disease PatientsCompletedNCT00852020Not applicable
• Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE LevelsWithdrawnNCT00851370Phase 2
• Systemic Inflammation in Chronic Obstructive Pulmonary Disease (COPD)Status unknownNCT00850863
• Effects of Smoking on Bronchial EpitheliumCompletedNCT00849433
• Efficacy of "On Line" Telematic SpirometryCompletedNCT00844116Not applicable
• Endothelial Dysfunction, Biomarkers, and Lung Function -Ancillary to MESAActive, not recruitingNCT00843271
• (Cost-)Effectiveness Interdisciplinary Community-based COPD Management Program (INTERCOM)CompletedNCT00840892Not applicable
• Trefoil Peptides in Lung DiseasesCompletedNCT00839735
• Evaluation of Symbicort® Turbuhaler® (Budesonide/Formoterol) in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00837629
• Unsupported Arm Exercise and Breathing Strategy in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00836108Not applicable
• The Chronic Obstructive Pulmonary Disease Fish Oil Pilot TrialCompletedNCT00835289Not applicable
• Study of the Effect of the ROX AC1 on Exercise Capacity and Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00832611Phase 4
• Endothelial Dysfunction in Chronic Obstructive Pulmonary DiseaseCompletedNCT00831220
• Detection of Circulating Endothelial Progenitors Cells (EPCs) in Non-small Cell Lung Cancer (NSCLC)CompletedNCT00826683Phase 3
• Anti-inflammatory Effects of Caffeine in Chronic Obstructive Pulmonary Disease (COPD) SubjectsWithdrawnNCT00826566Not applicable
• Innate Immune Responses in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00826163Phase 3
• Efficacy of Arm Training in COPD PatientsCompletedNCT00825032Not applicable
• Assessment of Treatment With PulseHaler on Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00821418Not applicable
• Application and Generalization of Flutter Mucus Clearance DeviceCompletedNCT00816881Not applicable
• A Registry of COPD Patients to be Used for Future StudiesCompletedNCT00814203
• A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.CompletedNCT00808288Phase 2
• Sensitivity of New Exercise Tests in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00807534Not applicable
• Responses Induced by Smoking in Individuals Being Susceptible and Non-Susceptible for Development of COPDStatus unknownNCT00807469
• A Healthy Volunteer Study With Inhaled GSK573719 and PlaceboCompletedNCT00803673Phase 1
• Trial Comparing Effect of He/O2 to Medical Air on Pulmonary Function DiseaseCompletedNCT00801307Phase 1/2
• NOWOX Oxygen Therapy Monitoring DeviceCompletedNCT00800072Not applicable
• Correlation of Airflow Limitation and Other Respiratory Characteristics With Radiologic Changes of Lung StructureStatus unknownNCT00799305
• Asthma, Inflammation and G Protein-coupled Receptors (GPCR)CompletedNCT00793676Not applicable
• End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)Status unknownNCT00792974
• Antibiotic/COPD in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) Requiring Mechanical VentilationCompletedNCT00791505Phase 3
• Evaluation of Remote Patient Monitoring.WithdrawnNCT00789100
• The Use of a Forecasting System for Predicting Exacerbations of COPDCompletedNCT00788645Early Phase 1
• COPD and Cardiovascular Risk in the PopulationCompletedNCT00787748
• Validation of PROMIS Banks With COPD ExacerbationsCompletedNCT00784342
• Investigating the Impact of Mode of Administration on Item ResponseCompletedNCT00783991
• Safety, Toleration and Efficacy of Single Inhaled Doses of PF-00610355 in Chronic Obstructive Pulmonary (COPD) Patients.CompletedNCT00783406Phase 2
• Bronchodilators and Respiratory Mechanics in Chronic Obstructive Pulmonary Disease (COPD) PatientsTerminatedNCT00783250Phase 4
• Aerosol Cyclosporine in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00783107Phase 1
• A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy SubjectsCompletedNCT00783003Phase 1
• Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00782535Phase 2
• Evaluation of Possible Effects on the QTc Interval of CHF 4226 pMDI in Healthy VolunteersCompletedNCT00777595Phase 1
• A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00774761Phase 2
• Pennsylvania Study Of Chronic Obstructive Pulmonary ExacerbationsCompletedNCT00774176
• A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) TreatmentCompletedNCT00772733
• Biomarkers and Genetic Factors Related to EmphysemaCompletedNCT00757120
• Analyzing Lung Tissue in People With and Without Chronic Obstructive Pulmonary Disease Who Are Undergoing Lung TransplantationCompletedNCT00756522
• Effectiveness of Home Automated Telemanagement in Chronic Obstructive Pulmonary DisorderCompletedNCT00752531Not applicable
• A Phase 1b Study to Evaluate the Safety and PK of MP-376 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00752414Phase 1
• Beta-Blocker in Chronic Obstructive Pulmonary Disease (COPD) StudyCompletedNCT00745043Not applicable
• Use Of Capnography As Surrogate Measure Of PC02 In Medical Intensive Care Unit (ICU) PatientsTerminatedNCT00744614
• A 12 Week Physical Training Programme for Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00744484Not applicable
• Formoterol Via pMDI HFA-134a Propellant or DPI in Partially Reversible Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00742248Phase 2
• The Effects of a Positive Expiratory Pressure (PEP) on Dyspnea and Dynamic Hyperinflation During Exercise in Chronic Obstructive Pulmonary Disease (COPD) PatientsStatus unknownNCT00741832Not applicable
• The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPDWithdrawnNCT00741767Not applicable
• Factors That Affect the Development of COPD SymptomsCompletedNCT00740337
• Coping Skills for Patients With Chronic Obstructive Pulmonary Disease (COPD) and Their CaregiversCompletedNCT00736268Not applicable
• Changes in Leukotrienes During Cardiac Surgery in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00734266
• EUROPT Clinical Trial to Study the Efficacy of One-Way Valve Implantation (New Treatment Algorithm) in Patients With Heterogeneous EmphysemaStatus unknownNCT00730301Phase 4
• Safety and Efficacy of 4-weeks Treatment of BIBW 2948 BS in Patients With Chronic Obstructive BronchitisWithdrawnNCT00726479Phase 2

← Pulmonary Disease, Chronic Obstructive overview